引用本文:戴怡萍,尹富强,王春来,孙雪梅,张锦焰,刘 夏.Garcinone C对鼻咽癌细胞溶酶体损伤的影响及相关机制研究[J].中国临床新医学,2025,18(4):396-401.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 88次   下载 61 本文二维码信息
码上扫一扫!
分享到: 微信 更多
Garcinone C对鼻咽癌细胞溶酶体损伤的影响及相关机制研究
戴怡萍1,尹富强2,王春来1,孙雪梅1,张锦焰3,刘 夏1
1.广西医科大学基础医学院,“长寿与老年相关疾病”教育部重点实验室,南宁 530021;2.广西医科大学生命科学研究院,南宁 530021;3.广西医科大学口腔医学院,南宁 530021
摘要:
[摘要] 目的 探讨Garcinone C对鼻咽癌细胞溶酶体损伤的影响及相关机制。方法 选择鼻咽癌细胞HONE1和S18进行实验,以Garcinone C进行干预处理。采用CCK-8实验检测细胞增殖活力,通过磷酸酯法检测酸性磷酸酶活性。采用免疫荧光实验检测溶酶体膜蛋白1(LAMP1)、半乳糖凝集素-3(Gal-3)、组织蛋白酶D(CTSD)的表达量,并观察其定位。通过Western blot实验检测CTSD、LAMP1、Gal-3、Ras相关蛋白Rab-7a(Rab7a)、囊泡相关膜蛋白8(VAMP8)的表达水平。结果 Garcinone C可抑制鼻咽癌细胞活力及酸性磷酸酶活性(P<0.05),促进胞质中LAMP1、Gal-3、CTSD表达量上升(P<0.05)。经Garcinone C干预后,鼻咽癌细胞CTSD、LAMP1、Gal-3、Rab7a蛋白表达水平显著上升(P<0.05),VAMP8蛋白表达水平显著下降(P<0.05),且调控作用呈剂量依赖性。结论 Garcinone C可能通过损伤鼻咽癌细胞溶酶体发挥治疗作用,有望成为鼻咽癌化疗药物开发的候选先导化合物。
关键词:  Garcinone C  鼻咽癌  溶酶体损伤
DOI:10.3969/j.issn.1674-3806.2025.04.08
分类号:
基金项目:国家自然科学基金项目(编号:82260721,81903644);广西自然科学基金重点项目(编号:2024GXNSFDA010045);广西医科大学大学生创新训练计划项目(编号:202310598054)
A study on effects of Garcinone C on lysosomal damage of nasopharyngeal carcinoma cells and their related mechanisms
DAI Yiping1, YIN Fuqiang2, WANG Chunlai1, SUN Xuemei1, ZHANG Jinyan3, LIU Xia1
1.School of Basic Medical Sciences, Key Laboratory of Longevity and Aging-Related Disease of Chinese Ministry of Education, Guangxi Medical University, Nanning 530021, China; 2.Life Sciences Institute, Guangxi Medical University, Nanning 530021, China; 3.Guangxi Medical University College of Stomatology, Nanning 530021, China
Abstract:
[Abstract] Objective To explore the effects of Garcinone C on lysosomal damage of nasopharyngeal carcinoma(NPC) cells and their related mechanisms. Methods NPC cells HONE1 and S18 were selected for experiment, and Garcinone C was used as intervention treatment. CCK-8 assay was used to detect cell proliferation viability, and the phosphate ester method was used to detect acid phosphatase activity. The expression levels of lysosomal-associated membrane protein 1(LAMP1), galectin-3(Gal-3) and cathepsin D(CTSD) were detected by using immunofluorescence assay, and their localizations were observed. The expression levels of CTSD, LAMP1, Gal-3, Ras-related protein Rab-7a(Rab7a) and vesicle-associated membrane protein 8(VAMP8) were detected by using Western blot. Results Garcinone C could inhibit the viability of NPC cells and the activity of acid phosphatase(P<0.05), and promote an increase in the expression levels of LAMP1, Gal-3 and CTSD in the cytoplasm(P<0.05). After intervention with Garcinone C, the expression levels of CTSD, LAMP1, Gal-3 and Rab7a proteins in NPC cells were significantly increased(P<0.05), while the expression level of VAMP8 protein was significantly decreased(P<0.05). These regulatory effects were dose-dependent. Conclusion Garcinone C may play a therapeutic role by damaging lysosomes of NPC cells. Garcinone C is expected to be a candidate lead compound in the development of chemotherapy drugs for NPC.
Key words:  Garcinone C  Nasopharyngeal carcinoma  Lysosomal damage